Management of Ductal Carcinoma in Situ of the Breast
- MeSH Terms
Carcinoma, Intraductal, Noninfiltrating, breast ductal carcinoma, recurrence score, 12 gene expression assay, Margin, Marginal
- Guideline Contact
- Lisa Durocher; [email protected]
- Keywords
- Ductal Carcinoma in Situ; DCIS; Breast Conserving Surgery; Mastectomy; Radiation; Tamoxifen; Anastrozole
- Date for Review
- The Program in Evidence-based Care (PEBC), Ontario Health (CCO) has an annual review process for each guideline. Guidelines are reviewed every fall, one year after they are completed.
- Publication Date
- March 31, 2024
- Date of Last Evidence Search
- November 27, 2023
- Methods Applied
- Evidence-based; Systematic review-based; External review; Evidence quality assessment; Patient/survivor/caregiver participation; GRADE approach
- Publication Scope
- treatment
- Countries of Application
- Canada
- Guideline Publication Status
- Published
- Languages
- English
- Authors
- PEBC (Program in evidenced-based care)
- Publication Year
- 2024